View Rule
| View EO 12866 Meetings | Printer-Friendly Version Download RIN Data in XML |
| HHS/CMS | RIN: 0938-AT91 | Publication ID: Spring 2020 |
| Title: International Pricing Index Model For Medicare Part B Drugs (CMS-5528)(Section 610 Review) | |
|
Abstract:
This proposed rule considers testing changes to payment for certain separately payable Part B drugs and biologicals. |
|
| Agency: Department of Health and Human Services(HHS) | Priority: Economically Significant |
| RIN Status: Previously published in the Unified Agenda | Agenda Stage of Rulemaking: Proposed Rule Stage |
| Major: Yes | Unfunded Mandates: No |
| EO 13771 Designation: Regulatory | |
| RFA Section 610 Review: Section 610 Review | |
| CFR Citation: 42 CFR 513 | |
| Legal Authority: Social Security Act, sec. 1115A | |
|
Legal Deadline:
None |
||||||||||||
Timetable:
|
| Regulatory Flexibility Analysis Required: Yes | Government Levels Affected: Federal, State |
| Small Entities Affected: Businesses | Federalism: No |
| Included in the Regulatory Plan: Yes | |
| International Impacts: This regulatory action will be likely to have international trade and investment effects, or otherwise be of international interest. | |
| RIN Data Printed in the FR: Yes | |
|
Agency Contact: Andrew York Social Science Research Analyst Department of Health and Human Services Centers for Medicare & Medicaid Services Center for Medicare and Medicaid Innovation, MS: WB-06-05, 7500 Security Boulevard, Baltimore, MD 21244 Phone:410 786-8945 Email: andrew.york1@cms.hhs.gov |
|
